Archive | Clinical Trials

Adjuvant Targeted Therapy Proves Beneficial in Resected Stage III BRAF-Mutant Melanoma

Targeted therapy use in melanoma has been extended beyond just metastatic disease to now include adjuvant therapy for patients with resected stage III melanoma.

Read the full story

Posted in Melanoma News, Health Professionals, Clinical Trials

mRNA-based therapeutic cancer vaccine enters Phase II trial

BioNTech is evaluating its investigational therapeutic mRNA-based cancer vaccine, BNT111, in combination with Libtayo® (cemiplimab) for the treatment of melanoma.

Read the full story

Posted in Melanoma News, Health Professionals, Clinical Trials

Belapectin/Pembrolizumab Shows Early Activity, Tolerability in Metastatic Melanoma & Head and Neck Cancer

The combination of the galactin-3 inhibitor belapectin (GR-MD-02) plus pembrolizumab (Keytruda) has demonstrated early potential for disease control with acceptable tolerability in patients with metastatic melanoma…

Read the full story

Posted in Melanoma News, Health Professionals, Clinical Trials

Novel Immunotherapy Combination Produces Durable Response in Untreated Metastatic Melanoma

An unmet need remains for novel immune checkpoint inhibitor combinations that achieve durable and deep responses in patients with metastatic melanoma, without adding substantial toxicity.

Read the full story

Posted in Melanoma News, Health Professionals, Clinical Trials